[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:IXHL":3,"prompts:company:0001873875":22,"buybacks:0001873875:12":49,"months:0001873875:36":91,"side:events:0001873875":113,"filings:0001873875":132},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001873875","Incannex Healthcare Limited","IXHL","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:IXHL","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":67,"recent_quarters":83,"did_asr":15,"asrs":90},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-06-30","2026-11-18T13:07:31.644351Z",{"value":54,"status":55,"as_of":51,"source":56},20000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0001628280-26-063506","10-K","2026-09-25","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1873875\u002F000162828026063506\u002F",{"value":62,"status":55,"as_of":51,"source":63},10602634,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":66},"2026-08-30",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[68],{"authorized":69,"unit":71,"authorized_as_stated":72,"price_as_of":14,"date_authorized":74,"expiration_date":76,"remaining":78,"remaining_as_stated":80,"description":82},{"value":54,"status":55,"as_of":51,"source":70},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"usd",{"value":54,"status":55,"as_of":51,"source":73},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":75,"as_of":14,"source":14},"not_found",{"value":65,"status":55,"as_of":51,"source":77},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":79},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":81},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"In August 2025, our Board of Directors authorized a $20 million share repurchase program pursuant to which the Company could repurchase up to $20 million of its outstanding shares of Common Stock. The share repurchase program expired on August 30, 2026.",[84],{"period_start":85,"period_end":51,"shares":86,"avg_price":87,"value_usd":88,"source":89},"2026-04-01",1811624,3.911949786489912,7086982.120000001,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[],{"company":92,"data_as_of":51,"items":93},{"cik":6,"name":7,"ticker":8,"exchange":9},[94,101,109],{"period_start":85,"period_end":95,"open_market_shares":96,"total_shares":96,"program_shares":96,"asr_shares":14,"avg_price":97,"value_usd":98,"remaining":99,"remaining_unit":71,"source":100},"2026-04-30",1298772,3.66,4753505.5200000005,18824224,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":102,"period_end":103,"open_market_shares":104,"total_shares":104,"program_shares":104,"asr_shares":14,"avg_price":105,"value_usd":106,"remaining":107,"remaining_unit":71,"source":108},"2026-05-01","2026-05-31",512852,4.55,2333476.6,17685076,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":110,"period_end":51,"open_market_shares":111,"total_shares":111,"program_shares":111,"asr_shares":14,"avg_price":111,"value_usd":111,"remaining":62,"remaining_unit":71,"source":112},"2026-06-01",0,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"view":114,"sort":115,"total":116,"generated_at":117,"items":118,"next_cursor":14},"all","newest",2,"2026-11-20T09:58:33.467888Z",[119,126],{"id":120,"type":121,"event_date":122,"company":123,"amount_usd":54,"amount_estimated":15,"shares":14,"headline":124,"source":125},"94efb0f0-9db5-5fc1-820a-e25d5fa2066f","authorization_expiring","2026-07-31",{"cik":6,"name":7,"ticker":8,"exchange":9},"Incannex Healthcare Limited's $20m repurchase authorization expires Aug 30, 2026",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"id":127,"type":128,"event_date":51,"company":129,"amount_usd":88,"amount_estimated":15,"shares":86,"headline":130,"source":131},"2024b566-aba8-5950-8adb-2437bab9e37c","quarterly_repurchase",{"cik":6,"name":7,"ticker":8,"exchange":9},"Incannex Healthcare Limited repurchased 1.8m shares ($7m) in the quarter to Jun 30, 2026",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"company":133,"items":134,"edgar_url":141},{"cik":6,"name":7,"ticker":8,"exchange":9},[135],{"accession":57,"form":58,"filed_at":136,"period_end":51,"url":60,"used_for":137},"2026-09-25T08:41:14Z",[138,139,140],"programs","recent_quarters","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001873875"]